Chief Excecutive Officer of IAG, with expertise in actively managing innovation in life science companies, asset positioning, strategy and capital.

Chair of IAG’s Scientifc Advisory Board and expert in global pharmaceutical R&D, developing treatments in immunology, neurology and oncology.

IAG’s Chief Technology Officer and AI Professor, recognized expert in imaging strategies and artificial intelligence to optimize data management and data analytics.

Chairman of IAG and operating partner of ArchiMed, recognized commercial leader in clinical research sector, investor and strategist.

IAG’s COO and drug development veteran with 20+ years of experience growing teams and scaling operations.

Robert is heavily involved into building a diversified investment portfolio composed of early to market stage products.

Member of IAG’s Scientific Advisory Board, NED and lead in precision medicine clinical research.

IAG’s Account Director with 13+ years Sales and Business Development experience within the Life Sciences industry.